£3.5M
Northern Gritstone and Parkwalk Advisors backed the seed round to support team expansion and product development.

Adsilico builds virtual patient populations for medical device testing.
adsilico develops in-silico trials solutions using virtual synthetic patient populations to improve medical device safety and accelerate research. The company originated as a spin-out from the University of Leeds.
Alejandro Frangi
Founder and Chief Scientific Officer
Sheena Macpherson
CEO and Co-Founder
Nishant Ravikumar
Co-Founder and Head of Virtual Populations
Zeike Taylor
Co-Founder and Head of Simulations
Northern Gritstone and Parkwalk Advisors backed the seed round to support team expansion and product development.